We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
REVLIMID lenalidomide 10mg capsule blister pack, Bristol-Myers Squibb Australia Pty Ltd, CON-1368
Product name
REVLIMID lenalidomide 10mg capsule blister pack
Sponsor name
Bristol-Myers Squibb Australia Pty Ltd
Batches
C002978; C002979
Consent start
Consent no.
CON-1368
Duration
The consent is effective from 17 June 2025 until 1 November 2026.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product does not conform because the product label contains the contact
details of the previous sponsor (Celegene Pty Ltd) in place of the current
sponsor (Bristol-Myers Squibb Australia Pty Ltd), following a transfer of the
sponsorship of the products.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines